The experience can be draining and disheartening, and many of us grow weary of trying. Have you found yourself, more and more ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

SOLUTION Group Bhd (SGB), through its wholly-owned subsidiary Solution Biologics Sdn Bhd (SOLBIO), has signed an exclusive ...

According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...

Biological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.

Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...

HYDERABAD: Jiangsu Recbio Technology Co. Ltd, a leading Chinese biopharmaceutical firm, has entered into a licensing and ...

The implementation of these three key pillars — vaccination, screening, and treatment — are critical in eliminating cervical ...

Jiangsu Recbio Technology and Biological E. Limited are partnering for HPV9 vaccine. Recbio will transfer technology to ...

The Ogun State Commissioner for Health, Dr Tomi Coker has said that the state plans to vaccinate over 2 million children aged ...

The US Secretary of Health and Human Services insists he will soon announce the "cause" of autism, but setting a fixed ...

Biological E Ltd. has partnered with Jiangsu Recbio Technology to commercialize the latter's HPV9 vaccine, REC603, in India.